An economic evaluation of the control of three notifiable fish diseases in the United Kingdom

Moran, Dominic; Fofana, Abdulai

doi:10.1016/j.prevetmed.2007.02.009

Cited by 29 publications

(25 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is acknowledged that diseases can cause considerable economic losses in fish production [1]. To reduce this loss, many applications have been made, and selective breeding for improved disease resistance in fish is one of them [2].…”

Section: Introductionmentioning

confidence: 99%

Comparison of Aeromonas salmonicida resistant and susceptible salmon families: A high immune response is beneficial for the survival against Aeromonas salmonicida challenge

Zhang¹,

Niu²,

Storset

et al. 2011

Fish & Shellfish Immunology

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

Comparison of Aeromonas salmonicida resistant and susceptible salmon families: A high immune response is beneficial for the survival against Aeromonas salmonicida challenge

Zhang¹,

Niu²,

Storset

et al. 2011

Fish & Shellfish Immunology

View full text Add to dashboard Cite

“…Benefit Direct and indirect advantages produced by the surveillance system. Not limited to money, benefits might include any losses avoided due to information provided by surveillance system: financial savings, better use of resources, improved animal production, improved public health, increased understanding about a disease, or increased trade Dufour (1999), Moran and Fofana (2007), Morris et al (1996)…”

Section: Discussionmentioning

confidence: 99%

SERVAL: A New Framework for the Evaluation of Animal Health Surveillance

Drewe

Hoinville

Cook

et al. 2013

Transbound Emerg Dis

View full text Add to dashboard Cite

Animal health surveillance programmes may change in response to altering requirements or perceived weaknesses but are seldom subjected to any formal evaluation to ensure that they provide valuable information in an efficient manner. The literature on the evaluation of animal health surveillance systems is sparse, and those that are published may be unstructured and therefore incomplete. To address this gap, we have developed SERVAL, a SuRveillance EVALuation framework, which is novel and aims to be generic and therefore suitable for the evaluation of any animal health surveillance system. The inclusion of socio-economic criteria ensures that economic evaluation is an integral part of this framework. SERVAL was developed with input from a technical workshop of international experts followed by a consultation process involving providers and users of surveillance and evaluation data. It has been applied to a range of case studies encompassing different surveillance and evaluation objectives. Here, we describe the development, structure and application of the SERVAL framework. We discuss users' experiences in applying SERVAL to evaluate animal health surveillance systems in Great Britain.

show abstract

“…Costs–benefit analysis (CBA) (Box 1) has been used to assess the benefits of disease control (Moran and Fofana, ). CBA places all costs and benefits of a project or decision over a set period of time on a common temporal footing.…”

Section: The Economics Of Disease Freedommentioning

confidence: 99%

“…In the aquatic sector, Aunsmo et al. () modelled the costs of pancreas disease in Norway, and Moran and Fofana () assessed the economics of control for listed exotic fish diseases in the UK.…”

Section: Introductionmentioning

confidence: 99%

Epidemiology and Economics Support Decisions about Freedom from Aquatic Animal Disease

Peeler

Otte

2014

Transbound Emerg Dis

View full text Add to dashboard Cite

Summary In this study, we review the application of epidemiology and economics to decision‐making about freedom from aquatic animal disease, at national and regional level, and recent examples from Europe. Epidemiological data (e.g. pathogen prevalence and distribution) determine the technical feasibility and cost of eradication. The eradication of pathogens which exist in wild populations, or in a latent state, is technically difficult, uncertain and expensive. Notably, the eradication of diseases of molluscs is rarely attempted because host populations (farmed and wild) cannot be completely removed from open water systems. Doubt about the success of eradication translates into uncertain ex‐ante cost estimates. Additionally, the benefits of an official disease‐free status cannot be estimated with any accuracy. For example, in Europe, official freedom from epizootic ulcerative syndrome and white spot syndrome virus has not been pursued, arguably because the evidence does not exist for the benefits (reduced risk of disease in wild populations) to be estimated and thus weighed against the costs of maintaining disease freedom (e.g. restriction on imports). Economic analysis must assess not only whether the benefits of disease freedom outweigh costs, but whether it is the economically optimal disease control option. Government may also want to compare investment in aquatic animal health with other opportunities. As resources become scarce, governments have sought to share costs of disease control with industry, and thus to ensure equity, the distribution benefits must be known so costs can be borne by those who benefit. The economic principles to support decisions about disease freedom are well established, but their application is constrained by lack of epidemiological data, which may explain the lack of economic analysis in support of aquatic animal management in Europe. The integration of epidemiology and economics in disease control planning will identify research aimed at improving the underpinning evidence base.

show abstract

An economic evaluation of the control of three notifiable fish diseases in the United Kingdom

Cited by 29 publications

References 11 publications

Comparison of Aeromonas salmonicida resistant and susceptible salmon families: A high immune response is beneficial for the survival against Aeromonas salmonicida challenge

Comparison of Aeromonas salmonicida resistant and susceptible salmon families: A high immune response is beneficial for the survival against Aeromonas salmonicida challenge

SERVAL: A New Framework for the Evaluation of Animal Health Surveillance

Epidemiology and Economics Support Decisions about Freedom from Aquatic Animal Disease

Contact Info

Product

Resources

About